CartiHeal

CartiHeal is a privately-owned medical device company headquartered in Israel and a pioneer in the field of cartilage regeneration. Cartilage damage affects millions of patients worldwide and typically leads to severe pain and disability. Hyaline cartilage has very limited healing capabilities once damaged. Research shows that untreated injuries to articular cartilage may lead to progressive joint changes and early-onset osteoarthritis. A simple, well-tolerated, and effective solution for cartilage repair and regeneration represents one of the most challenging unmet needs in medicine.CartiHeal’s flagship product, the Agili-C™ implant, represents a significant medical breakthrough. This implant has demonstrated the ability to promote the regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous materials. The cell-free implant is inserted either arthroscopically or through minimally invasive methods.